Kidney transplant recipients treated with belatacept exhibit increased naïve and transitional B cells.
about
Role of B cells in tolerance inductionAntibody Subclass Repertoire and Graft Outcome Following Solid Organ TransplantationMethylation of FOXP3 TSDR Underlies the Impaired Suppressive Function of Tregs from Long-term Belatacept-Treated Kidney Transplant PatientsIntravenous immunoglobulin therapy in kidney transplant recipients with de novo DSA: Results of an observational study.Immune Profiles to Predict Response to Desensitization Therapy in Highly HLA-Sensitized Kidney Transplant CandidatesPostdepletion Lymphocyte Reconstitution During Belatacept and Rapamycin Treatment in Kidney Transplant Recipients.Regulatory B Cells in Pregnancy: Lessons from Autoimmunity, Graft Tolerance, and Cancer.Effect of Immunosuppressive Drugs on Humoral Allosensitization after Kidney Transplant.mTOR inhibitors and risk of chronic antibody-mediated rejection after kidney transplantation: where are we now?Maintenance immunosuppressants in the management of antibody-mediated renal allograft rejection: which regimen is best?Transplantation tolerance: don't forget about the B cells.Belatacept Does Not Inhibit Follicular T Cell-Dependent B-Cell Differentiation in Kidney Transplantation.NO AUGMENTATION OF INDOLEAMINE 2,3-DIOXYGENASE (IDO) ACTIVITY THROUGH BELATACEPT TREATMENT IN LIVER TRANSPLANT RECIPIENTS.Transcriptomic Signature of the CD24hi CD38hi Transitional B Cells Associated With an Immunoregulatory Phenotype in Renal Transplant Recipients.Control of Humoral Response in Renal Transplantation by Belatacept Depends on a Direct Effect on B Cells and Impaired T Follicular Helper-B Cell Crosstalk.
P2860
Q26824451-B913FF1F-22F1-4AB6-87BE-3BCC356B05A2Q28076193-B938E6BB-0611-455A-B29B-EA516B169A52Q30360800-57E35886-12B1-4A5B-A7B7-1739D73346BCQ33842250-DAFB7FF3-4045-4AF9-A941-7871FBC875DAQ35990094-0FCF9C2D-B08D-4222-A936-CC786280FD9FQ36769110-A73C60A4-AE2A-4624-870C-419608F57D31Q37647575-CBA0C5DE-60BA-4683-A96D-00E683F664E9Q38731333-4D023883-B972-40D0-B437-EC629A3E200DQ38818479-A0570B46-A9FF-4305-8CE3-9D2EFB2DD49BQ39045577-82475B54-6FAF-4A9B-A265-6D759ED31F45Q39093942-F360783B-FCF5-40A3-8700-65C4B0C5663BQ42235846-3617CAC2-D52C-44C3-8066-5876C5B32D87Q47260341-7D561334-6FF4-4AA3-8FF4-64D08FFAF006Q47869731-DBF76A6D-F52E-4463-A1E8-1E955FF97698Q50102293-ECF90F51-B12B-4EA2-ACBB-970EF3DE200B
P2860
Kidney transplant recipients treated with belatacept exhibit increased naïve and transitional B cells.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Kidney transplant recipients t ...... aïve and transitional B cells.
@en
Kidney transplant recipients t ...... aïve and transitional B cells.
@nl
type
label
Kidney transplant recipients t ...... aïve and transitional B cells.
@en
Kidney transplant recipients t ...... aïve and transitional B cells.
@nl
prefLabel
Kidney transplant recipients t ...... aïve and transitional B cells.
@en
Kidney transplant recipients t ...... aïve and transitional B cells.
@nl
P2093
P2860
P356
P1476
Kidney transplant recipients t ...... aïve and transitional B cells.
@en
P2093
E D Carosella
F Montespan
M Matignon
N Rouas-Freiss
P Grimbert
P2860
P304
P356
10.1111/AJT.12721
P407
P577
2014-04-14T00:00:00Z